comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-27 19:28:02 - browse：4

Brain cancer — Michelle Monje/Stanford University/NIH

Tocagen (TOCA) said Tuesday that a Phase 3 clinical trial involving a novel gene therapy for aggressive brain tumors will continue to a final analysis later this year, following an interim look at patient survival data conducted by independent monitors. Tocagen’s stock price dropped sharply.

The San Diego-based biotech pitched the study’s continuation as an encouraging sign for its gene therapy called Toca 511/Toca FC, which is designed to deliver a localized chemotherapy directly to the site of brain tumors.

“We believe the longer-term follow-up of patients in the final analysis, particularly for those randomized in the second enrollment period, will be important in assessing both primary and secondary endpoints,” said Tocagen CEO Marty Duvall, in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Ionis has late

Wikipedia

WSS

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

EMA weighs against approval for Mirati's lung cancer drug

WHO recommends dropping component of many flu vaccines

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

knowledge

comprehensive

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Address the ethical violations that led to 'Three Identical Strangers'

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Listen: BridgeBio's big week & Lilly's Alzheimer's data

In age of alternative facts, a scholarly course on calling out crap

Intercept Pharmaceuticals sells itself for less than $1 billion

Supreme Court strikes down use of affirmative action

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biogen shutters digital health group, ends Apple study, in cost cutting move

focus

Address the ethical violations that led to 'Three Identical Strangers'

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

FDA seeks to regulate lab

A new deal aims to ramp up use of AI in rehab care decisions

Listen: BridgeBio's big week & Lilly's Alzheimer's data

focus

Wikipedia

hotspot

focus